Farallon Capital Management LLC Kura Oncology, Inc. Transaction History

Farallon Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$20.85 - $29.88 $4.17 Million - $5.98 Million	-200,000 Reduced 50.0%	200,000 $4.17 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $6.81 Million - $10.8 Million	275,000 Added 220.0%	400,000 $11.3 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $3.63 Million - $5.2 Million	125,000 New	125,000 $4.08 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.